Haemair
Haemair is a company dedicated to developing life-saving medical technology, particularly in the field of extracorporeal life support and organ perfusion. Founded by engineers with personal connections to lung disease, their mission is to create innovative devices that improve patient outcomes, reduce the need for transplants, and minimize animal testing. Their focus includes developing pulsatile blood pumps, blood oxygenators, and systems for ex-vivo organ support, with applications in transplant, surgery, drug testing, and treatment of comorbidities such as ARDS and AKI. They have received patents, grants, and have a team of qualified engineers and scientists committed to advancing medical device technology.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Passive mass-exchange transfusion line device
A simple inline mass-exchange device designed to reduce concentrations of toxic species (e.g., potassium, free iron, free haem) in stored transfusion blood without external services or moving parts.
Pulsatile low-haemolysis blood pump (pump head replaceable)
A pulsatile blood pump architecture that reproduces physiological pulse profiles and is designed to cause lower haemolysis than standard centrifugal or peristaltic pumps; the blood-contacting pump head is a replaceable, single-use component.
Compact oxygenator modules (flat-sheet and straight-fibre variants)
Oxygenator modules using either flat-sheet membranes or straight hollow-fibre geometries to enable smoother blood flow, higher gas-transfer rates and compact form-factors suitable for ECLS and organ perfusion applications.
Two-phase oxygenator for combined respiratory and renal support
Prototype two-phase gas/liquid oxygenators that transfer oxygen/CO2 and extract small solutes (e.g., urea, creatinine) into a liquid phase, enabling a single device to provide auxiliary lung and kidney functions.
Passive mass-exchange transfusion line device
A simple inline mass-exchange device designed to reduce concentrations of toxic species (e.g., potassium, free iron, free haem) in stored transfusion blood without external services or moving parts.
Pulsatile low-haemolysis blood pump (pump head replaceable)
A pulsatile blood pump architecture that reproduces physiological pulse profiles and is designed to cause lower haemolysis than standard centrifugal or peristaltic pumps; the blood-contacting pump head is a replaceable, single-use component.
Compact oxygenator modules (flat-sheet and straight-fibre variants)
Oxygenator modules using either flat-sheet membranes or straight hollow-fibre geometries to enable smoother blood flow, higher gas-transfer rates and compact form-factors suitable for ECLS and organ perfusion applications.
Two-phase oxygenator for combined respiratory and renal support
Prototype two-phase gas/liquid oxygenators that transfer oxygen/CO2 and extract small solutes (e.g., urea, creatinine) into a liquid phase, enabling a single device to provide auxiliary lung and kidney functions.
Services
Design, fabrication and bench testing of extracorporeal device prototypes including haemolysis and gas-transfer performance evaluations.
Development and demonstration of integrated perfusion systems for maintaining organ viability ex-vivo for transplant assessment, drug testing and ex-vivo treatment workflows.
Development and calibration of autonomic-inspired closed-loop control systems to manage extracorporeal devices, intended to reduce clinician workload and improve patient mobility.
Management and delivery of innovation projects under competitive grant schemes and collaboration with external partners for targeted technology development.
Design, fabrication and bench testing of extracorporeal device prototypes including haemolysis and gas-transfer performance evaluations.
Development and demonstration of integrated perfusion systems for maintaining organ viability ex-vivo for transplant assessment, drug testing and ex-vivo treatment workflows.
Development and calibration of autonomic-inspired closed-loop control systems to manage extracorporeal devices, intended to reduce clinician workload and improve patient mobility.
Management and delivery of innovation projects under competitive grant schemes and collaboration with external partners for targeted technology development.
Expertise Areas
- Extracorporeal life support (ECMO) system development
- Pulsatile pump design and haemocompatibility
- Oxygenator membrane and mass-transfer engineering
- Organ perfusion and preservation technologies
Key Technologies
- Extracorporeal membrane oxygenation (ECMO/ECLS)
- Pulsatile blood pumping technology
- Flat-sheet membrane oxygenators
- Straight hollow-fibre oxygenator designs
News & Updates
The patent awarded in Europe in October 2021 is now being approved in other territories. The device offers benefits of pulsing flow and extremely low haemolysis, with applications in organ perfusion, surgery, and drug testing.
A project on ex-vivo support of organs and tissues to improve transplant success and salvage rejected organs, supported by Welsh Government.
Supported by a grant from Innovate UK, developing a device to treat ARDS and AKI comorbidities, which have high mortality rates.
Patent awarded in Europe in October 2021, now being approved in other territories, for a device with pulsing flow and low haemolysis.
The patent awarded in Europe in October 2021 is now being approved in other territories. The device offers benefits of pulsing flow and extremely low haemolysis, with applications in organ perfusion, surgery, and drug testing.
A project on ex-vivo support of organs and tissues to improve transplant success and salvage rejected organs, supported by Welsh Government.
Supported by a grant from Innovate UK, developing a device to treat ARDS and AKI comorbidities, which have high mortality rates.
Patent awarded in Europe in October 2021, now being approved in other territories, for a device with pulsing flow and low haemolysis.